| Literature DB >> 23217713 |
Jorge L Ruas1, James P White, Rajesh R Rao, Sandra Kleiner, Kevin T Brannan, Brooke C Harrison, Nicholas P Greene, Jun Wu, Jennifer L Estall, Brian A Irving, Ian R Lanza, Kyle A Rasbach, Mitsuharu Okutsu, K Sreekumaran Nair, Zhen Yan, Leslie A Leinwand, Bruce M Spiegelman.
Abstract
PGC-1α is a transcriptional coactivator induced by exercise that gives muscle many of the best known adaptations to endurance-type exercise but has no effects on muscle strength or hypertrophy. We have identified a form of PGC-1α (PGC-1α4) that results from alternative promoter usage and splicing of the primary transcript. PGC-1α4 is highly expressed in exercised muscle but does not regulate most known PGC-1α targets such as the mitochondrial OXPHOS genes. Rather, it specifically induces IGF1 and represses myostatin, and expression of PGC-1α4 in vitro and in vivo induces robust skeletal muscle hypertrophy. Importantly, mice with skeletal muscle-specific transgenic expression of PGC-1α4 show increased muscle mass and strength and dramatic resistance to the muscle wasting of cancer cachexia. Expression of PGC-1α4 is preferentially induced in mouse and human muscle during resistance exercise. These studies identify a PGC-1α protein that regulates and coordinates factors involved in skeletal muscle hypertrophy.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23217713 PMCID: PMC3520615 DOI: 10.1016/j.cell.2012.10.050
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582